POSTUPAK HITNE KONTRACEPCIJE

• 收藏
• 分享

专利权人:

Laboratoire HRA Pharma;The United States of America, as represented by The Secretary, Department of Health and Human Services Office of Technology Transfer, National Institutes of Health

发明人:

Ulmann, André,Gainer, Erin,Blithe, Diana,Nieman, Lynette,Mathe, Henri Camille,Ulmann, AndrĂ©

申请号：

HRP20161437

公开号：

HRP20161437T1

申请日:

2016.11.02

申请国别(地区):

HR

年份:

2017

代理人:

摘要：

The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator, such as 17a-acetoxy-llb-[4-N, N-dimethylamino-phenyl)-19-norpregna- 4, 9-diene-3, 20-dione (ulipristal acetate) in a woman, within 72 hours before an intercourse or within 120 hours after the intercourse.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/